Article
[PDF] Business and Economic Development: Pharmaceutical Sector Report
[refers to Merck, Novo Nordisk, Aspen Pharmacare, Grunenthal, Novartis, Citadel Aurobindo Biotech & Citadel Fine Pharmaceuticals (both part of Aurobindo Pharmaceuticals), Abbott Laboratories, Bristol Myers-Squibb, Pfizer, Schering-Plough, Eli Lilly, Phytopharm, Ranbaxy Laboratories, Cipla, GlaxoSmithKine, Birzeit, AstraZeneca, Aventis, Boehringer Ingelheim, Forest Laboratories, Roche, Wyeth]